皓宸医疗科技股份有限公司 2025 年半年度报告全文 皓宸医疗科技股份有限公司 2025 年半年度报告 2025 年 8 月 所有董事均已出席了审议本次半年报的董事会会议。 半年度报告中所涉及未来的经营计划和经营目标，并不代表公司的盈利 预测，也不构成公司对投资者的实质承诺，能否实现取决于市场状况变化等 多种因素，存在不确定性，请投资者注意投资风险。 公司在经营中可能存在的风险因素内容已在本报告"第三节 管理层讨论 与分析"之"十、公司面临的风险和应对措施"部分予以描述，敬请投资者 仔细阅读并注意风险。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 1 皓宸医疗科技股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司负责人陆璐、主管会计工作负责人邓强及会计机构负责人(会计主管 人员)王延肖声明：保证本半年度报告中财务报告的真实、准确、完整。 | | . | | | --- | --- | --- | | | 4 | | ...

Market Overview - On August 27, the medical services sector declined by 2.14%, with Haitai Biological leading the drop [1] - The Shanghai Composite Index closed at 3800.35, down 1.76%, while the Shenzhen Component Index closed at 12295.07, down 1.43% [1] Stock Performance - Notable gainers in the medical services sector included: - Digital Human: Closed at 17.23, up 12.84% with a trading volume of 200,800 shares and a turnover of 355 million [1] - Nanmo Biology: Closed at 62.11, up 8.34% with a trading volume of 41,300 shares and a turnover of 250 million [1] - Dian Diagnostics: Closed at 17.49, up 5.81% with a trading volume of 813,500 shares and a turnover of 1.467 billion [1] - Major decliners included: - Haitai Biological: Closed at 51.28, down 6.87% with a trading volume of 128,800 shares and a turnover of 684 million [2] - Hongbo Pharmaceutical: Closed at 37.93, down 5.79% with a trading volume of 125,600 shares and a turnover of 498 million [2] - Huacheng Medical: Closed at 3.78, down 5.74% with a trading volume of 843,900 shares and a turnover of 328 million [2] Capital Flow - The medical services sector experienced a net outflow of 1.677 billion from institutional investors, while retail investors saw a net inflow of 951 million [2][3] - Key stocks with significant capital flow included: - Jinyu Medical: Net inflow of 120 million from institutional investors, but a net outflow of 79 million from retail investors [3] - Huada Gene: Net inflow of 107 million from institutional investors, with outflows from both retail and speculative investors [3] - Dian Diagnostics: Net inflow of 65.5 million from institutional investors, with outflows from speculative and retail investors [3]

Company Overview - Haochen Medical's stock price closed at 4.01 yuan on August 26, down 0.09 yuan, a decline of 2.20% from the previous trading day [1] - The company operates in the medical services sector, with concepts including medical beauty and smart grid [1] - Haochen Medical has a total market capitalization of 3.368 billion yuan, with circulating market value equal to total market value [1] Stock Performance - On August 26, the stock opened at 4.13 yuan, reached a high of 4.17 yuan, and a low of 4.01 yuan, with a trading volume of 793,867 hands and a transaction amount of 323 million yuan [1] - During the early trading session, the stock experienced a rapid rebound, increasing over 2% within 5 minutes, with a price of 4.13 yuan at 9:35 AM and a transaction amount of 34.93 million yuan [1] Capital Flow - On August 26, there was a net outflow of 2.1781 million yuan from the main funds, accounting for 0.06% of the circulating market value [1] - Over the past five trading days, the cumulative net inflow of main funds was 204.419 million yuan, representing 6.07% of the circulating market value [1]

Group 1 - The stock of Haocen Medical (002622) closed at 4.21 yuan on August 22, 2025, with a 9.92% increase, reaching the daily limit [1][2] - The trading volume for Haocen Medical on the same day was 1.4424 million hands, with a total transaction amount of 585 million yuan [1][2] - The closing order funds amounted to 73.0896 million yuan, representing 2.07% of its circulating market value [1][2] Group 2 - At 13:33, the stock reached its daily limit and closed at 4.21 yuan without being opened again [2] - The net inflow of main funds was 116 million yuan, while retail funds showed a net outflow of 33.2009 million yuan [2] - The net outflow of speculative funds was 82.7291 million yuan [2]

Market Performance - On August 22, the medical services sector rose by 1.29%, with Berry Genomics leading the gains [1] - The Shanghai Composite Index closed at 3825.76, up 1.45%, while the Shenzhen Component Index closed at 12166.06, up 2.07% [1] Top Gainers in Medical Services - Berry Genomics (000710) closed at 15.79, up 10.03% with a trading volume of 749,900 shares and a turnover of 1.153 billion yuan [1] - Haochen Medical (002622) closed at 4.21, up 9.92% with a trading volume of 1.4424 million shares and a turnover of 585 million yuan [1] - Golden Domain Medical (603882) closed at 11, up 4.02% with a trading volume of 148,600 shares and a turnover of 461 million yuan [1] Top Losers in Medical Services - Boji Pharmaceutical (300404) closed at 11.37, down 5.09% with a trading volume of 490,800 shares and a turnover of 557 million yuan [2] - ST Shenghua (000504) closed at 9.79, down 3.83% with a trading volume of 85,800 shares and a turnover of 84.73 million yuan [2] - Chengda Pharmaceutical (301201) closed at 30.34, down 3.38% with a trading volume of 104,000 shares and a turnover of 320 million yuan [2] Capital Flow Analysis - The medical services sector experienced a net outflow of 153 million yuan from institutional investors, while retail investors saw a net inflow of 246 million yuan [2][3] - Berry Genomics had a net inflow of 468 million yuan from institutional investors, but a net outflow of 214 million yuan from speculative funds [3] - Haochen Medical saw a net inflow of 116 million yuan from institutional investors, with a net outflow of 82.73 million yuan from speculative funds [3]

Group 1 - The core viewpoint of the news is that Haocen Medical has experienced a significant stock price increase, reaching a limit up of 9.92% on August 22, with a trading price of 4.21 yuan per share and a total market capitalization of 3.536 billion yuan [1] - Haocen Medical is primarily engaged in oral medical services and industrial manufacturing, with a focus on the research and innovation of permanent magnet switch products [1] - The company was listed on the Shenzhen Stock Exchange in 2011 and acquired a controlling stake in Guangdong Delun Medical Group in 2021 [1] Group 2 - As of March 31, Haocen Medical had 54,000 shareholders, with an average of 15,500 circulating shares per shareholder [2] - For the first quarter of 2025, Haocen Medical reported operating revenue of 143 million yuan, a year-on-year decrease of 12.58%, and a net profit attributable to shareholders of -12.2146 million yuan, a year-on-year decrease of 167.13% [2]

风险提示：股市有风险，投资需谨慎。 来源：金融界 截至2025年8月20日15时，皓宸医疗股价报3.96元，较前一交易日上涨0.36元。当日开盘价为3.64元，最 高触及3.96元，最低下探3.63元，成交量为826976手，成交金额达3.22亿元。 皓宸医疗属于医疗服务板块，公司业务涉及医疗美容、智能电网等领域。作为吉林地区上市公司，其总 市值为33.26亿元，流通市值与总市值相同。 从资金流向来看，皓宸医疗8月20日主力资金净流入11432.44万元，占流通市值的3.44%。近五个交易日 累计净流入17063.97万元，占比达5.13%。在医药生物行业整体资金净流出80.96亿元的背景下，皓宸医 疗成为该行业资金净流入排名第六的个股。 ...

Market Overview - On August 20, the medical services sector rose by 0.33% compared to the previous trading day, with Haocen Medical leading the gains [1] - The Shanghai Composite Index closed at 3766.21, up 1.04%, while the Shenzhen Component Index closed at 11926.74, up 0.89% [1] Top Gainers in Medical Services - Haocen Medical (002622) closed at 3.96, up 10.00% with a trading volume of 827,000 shares and a transaction value of 322 million yuan [1] - Meinian Health (002044) closed at 5.87, up 4.45% with a trading volume of 2,284,200 shares and a transaction value of 1.323 billion yuan [1] - Baicheng Pharmaceutical (301096) closed at 56.47, up 3.31% with a trading volume of 72,900 shares and a transaction value of 401 million yuan [1] Top Losers in Medical Services - Innovation Medical (002173) closed at 23.05, down 7.21% with a trading volume of 1,255,900 shares and a transaction value of 2.968 billion yuan [2] - Boji Pharmaceutical (300404) closed at 12.36, down 6.01% with a trading volume of 819,000 shares and a transaction value of 1.015 billion yuan [2] - Nanmo Biological (688265) closed at 61.50, down 5.38% with a trading volume of 32,800 shares and a transaction value of 201 million yuan [2] Capital Flow Analysis - The medical services sector experienced a net outflow of 2.075 billion yuan from institutional investors, while retail investors saw a net inflow of 1.893 billion yuan [2][3] - The top net inflow from retail investors was in Meinian Health (002044) with 201 million yuan, despite a net outflow from institutional investors [3] - Haocen Medical (002622) had a net inflow of 114 million yuan from institutional investors, but also faced significant outflows from retail investors [3]

天眼查商业履历信息显示，皓宸医疗科技股份有限公司，成立于1998年，位于吉林市，是一家以从事卫 生为主的企业。企业注册资本84000万人民币，实缴资本11198.74万人民币。公司法定代表人为陆璐。 金融界消息 截至2025年8月20日收盘，皓宸医疗（002622）报收于3.96元，上涨10.0%，换手率9.85%， 成交量82.70万手，成交金额3.22亿元。 资金流向方面，今日主力资金净流入1.14亿元，占比成交额35.55%。其中，超大单净流入1.30亿元、占 成交额40.47%，大单净流出1583.43万元、占成交额4.92%，中单净流出流出4474.20万元、占成交额 13.91%，小单净流出6958.23万元、占成交额21.64%。 皓宸医疗最新一期业绩显示，截至2025一季报，公司营业总收入1.43亿元、同比减少12.58%，归属净利 润1221.46万元，同比减少167.13%，扣非净利润1254.62万元，同比减少166.97%，流动比率0.311、速动 比率0.254、资产负债率71.09%。 通过天眼查大数据分析，皓宸医疗科技股份有限公司共对外投资了13家企业，参与招投标项目42次，知 ...

Core Viewpoint - The stock price of Haocen Medical has experienced a decline, closing at 3.60 yuan, down 3.74% from the previous trading day, indicating volatility in the market [1] Group 1: Stock Performance - As of August 19, 2025, at 15:00, Haocen Medical's stock price was reported at 3.60 yuan, a decrease of 3.74% from the previous trading day [1] - The opening price for the day was 3.68 yuan, with a high of 3.74 yuan and a low of 3.56 yuan [1] - The trading volume reached 805,400 hands, with a total transaction amount of 291 million yuan [1] - A rapid rebound occurred at 9:45 AM, with a price increase of over 2% within 5 minutes, reaching 3.65 yuan and a transaction amount of 85.46 million yuan during that period [1] - The net outflow of main funds for the day was 13.51 million yuan, while the cumulative net inflow over the past five trading days was 54.27 million yuan [1] Group 2: Company Overview - Haocen Medical's main business includes medical services and medical beauty, with its registered location in Jilin Province [1] - The company is also involved in smart grid and other business directions [1]